Novo Nordisk A S (NVO) Profit After Tax (2012 - 2016)

Novo Nordisk A S (NVO) has 5 years of Profit After Tax data on file, last reported at $1.5 billion in Q2 2016.

• Quarterly Profit After Tax rose 22.75% year-over-year to $1.5 billion in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $5.4 billion (up 8.05% YoY) and the FY2019 annual result came in at $39.0 billion, up 0.84% from the prior year.
• Profit After Tax rose to $1.5 billion in Q2 2016, from $1.4 billion in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.5 billion in Q2 2016 to a low of $822.0 million in Q1 2012.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2013 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2013 — Profit After Tax increased 28.83% — and 2016, when it slipped 6.43%.
• Tracing NVO's Profit After Tax over 5 years: stood at $1.0 billion in 2012, then gained by 10.5% to $1.1 billion in 2013, then slipped by 1.36% to $1.1 billion in 2014, then rose by 11.01% to $1.2 billion in 2015, then rose by 24.88% to $1.5 billion in 2016.
• The last three Profit After Tax figures came in at $1.5 billion (Q2 2016), $1.4 billion (Q1 2016), and $1.2 billion (Q4 2015), per Business Quant data.